Navigation Links
3SBio Inc. Announces Unaudited Second Quarter 2009 Results
Date:8/11/2009

378 55 Iron 3,455 504 Export 4,702 686 Others 34 5 Total net revenues 115,031 16,771 Cost of revenues (10,047) (1,464) Gross profit 104,984 15,307 Operating expenses Research and development costs (5,591) (815) Sales, marketing and distribution expenses (51,787) (7,550) General and administrative expenses (16,047) (2,340) Total operating expenses (73,425) (10,705) Operating income 31,559 4,602 Other income /(expenses), net Interest income 12,576 1,834 Grant income 187 27 Others 3,819 557 Total other income, net 16,582 2,418 Income before income tax expense and minority interests 48,141 7,019 Income tax expense (6,920) (1,009) Income before minority interests 41,221 6,010 Minority interests, net of tax 95 14 Net income 41,316 6,024 Net income per share: Basic and diluted 0.27 0.04 Basic weighted average number of shares outstanding 152,099,155 152,099,155 Effect of dilutive potential shares 4,318 4,318 Diluted weighted average number of shares outstanding 152,103,473 152,103,473 Net income per ADS: Basic and diluted 1.90
'/>"/>
SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. 3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009
2. 3SBio Inc. Announces Unaudited First Quarter 2009 Results
3. 3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP
4. 3SBio Inc. Announces Filing of Annual Report on Form 20-F
5. 3SBio Inc. to Present at The CIBC World Markets 18th Annual Healthcare Conference
6. Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results
7. Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors
8. Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
9. Leading Medical Developer Announces Plans for Texoma Medical Plaza
10. iMedX Announces Investment of $13M From RFE Investment Partners
11. Health Market Science Announces Commercial Release of CompleteSpend V2.5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...choice.com Enables Personal Health Record Devices ... Washington, PA (PRWEB) December 2, 2009 -- Perhap...read their own medical records. With the advent of...ersonal medical records is easier than ever. MyEMR... technology company has added services that will p...
(Date:12/2/2009)...ng medical device software engineering consulting ... certification. A relatively few medical device so...achieved ISO 13485 certification. Many medical dev... to other ISO standards as well. However, it is so...ing consulting firm to achieve the rigorous qualit...
(Date:12/2/2009)...Newswire/ -- A randomized, controlled study compar...nvasive treatment called percutaneous disc decompr...ile both treatments help patients in the short run...up to two years later. Results of the study, the f...al meeting of the Radiological Society of North Am...
(Date:12/2/2009)...asound of suspicious areas of the breast, includin...ternative to invasive biopsies for women under age...ented today at the annual meeting of the Radiologi...rming high-quality breast ultrasound, we can reduc...iagnostic procedures in young women," said senior ...
(Date:12/1/2009)...ate Christ Medical Center in Oak Lawn, Ill. has be...nter and the first for Chicago’s south and s... hospital’s plans today (December 1) by the ...rd. , Springfield, Ill. (...Lawn, Ill. has become the state’s newest kid...
Breaking Medicine News(10 mins):Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3
...alting a medication that treats one ailment becaus...ecision that elderly patients with multiple medica...s at Yale School of Medicine report in a study pub... and 24 percent have four or more. The study highl...
...a-Hydrating Lip Balm with a Slant-Tipped Applicato...eens and Walgreens.com, MILWAUKEE, Oct. 28 Carma...alm products, today announced the arrival of new C...Available exclusively at Walgreens and Walgreens.c...
...stein Speaks Directly to Voters in New Television ...Prop 8,campaign released a new television spot fea...tly to voters, tells Californians "Proposition 8 w...d and independent voice of,Senator Feinstein joini...
...y finds molecules convey genetic instructions from...SDAY, Oct. 28 (HealthDay News) -- What proteins a ... by an extensive network of regulatory interaction...carrying genetic instructions from a cell,s nuclei...
...third lower mortality for hospitalized patients, s... News) -- The death rate among people hospitalized...g statins than for those not taking the cholestero...ins as infection fighters, experts said. , "I thin...
...rd Third Quarter Sales, SALT LAKE CITY, Oct. 28 ... producer of advanced digital hearing aids,today a...mber 30, 2008., Third quarter highlights:, -- A... 2007. -- Launched three new products to further ...
Other Medicine News:Health News:Elderly fare better when included in decisions on treatment trade-offs 2Health News:Elaborate Network Drives When and Where Proteins Are Made 2Health News:Statins Reduced Death Risk From Pneumonia 2Health News:Statins Reduced Death Risk From Pneumonia 3Health News:Sonic Innovations Announces Results for Third Quarter 2008 2Health News:Sonic Innovations Announces Results for Third Quarter 2008 3Health News:Sonic Innovations Announces Results for Third Quarter 2008 4Health News:Sonic Innovations Announces Results for Third Quarter 2008 5Health News:Sonic Innovations Announces Results for Third Quarter 2008 6Health News:Sonic Innovations Announces Results for Third Quarter 2008 7Health News:Sonic Innovations Announces Results for Third Quarter 2008 8
(Date:12/1/2009)..., Dec. 1 The new position of Execu...ip Biotechnologies, Inc. has been taken up by Howa... more than 30 years of experience creating and man...stein will direct Microchip Biotechnologies, marke...vice operations as the company makes the transitio...
(Date:12/1/2009)...1 CCS Medical, Inc. a leading dire... announced that it has received approval from the ...aware (the "Court") for its bidding procedures in ... substantially all of its assets. ,, Pursuant t...oved bidding procedures for the sale of substantia...
(Date:12/1/2009)...swire-FirstCall/ -- CryoLife, Inc. ( CRY) , an im...ular tissue processing company, announced its init... expects total revenues for the full year of 2010 ...hich includes between $1.5 million and $2.5 millio...of Defense in connection with the development of B...
Breaking Medicine Technology:Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Global sunscreen wont save corals 8863 1Global sunscreen wont save corals 8863 2Spinal Decompression Therapy Offers Hope for Back Pain 49093 1Spinal Decompression Therapy Offers Hope for Back Pain 49093 2Potential for noninvasive brain tumor treatment 49089 1Potential for noninvasive brain tumor treatment 49089 2
...gned to Compare Efficacy of Bevasiranib Administe...entis(R) Administered Every 4... OPK ),today announced that the first patient has ...ranib And Lucentis Therapy) clinical trial of beva...ar degeneration (wet AMD). The,multi- national tri...
...Aug. 29 ,Exelixis, Inc. (Nasdaq: EXEL ) announced...alysts and investors in conjunction with the Inter...s (IASLC) 12th World Conference on,Lung Cancer. Th...2007, at,5:00 a.m. PDT/8:00 a.m. EDT. During the w... a Phase 2 trial of XL647 in non-small cell lung c...
Other Medicine Technology:Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 2Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 3Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 4Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing 2
...nsive hemodynamic monitoring and information manag...raphics, clinical hemodynamic data, hemodynamic wa... all flow seamlessly into one complete cardiac pat...Both images and information are accessible on a si...
EXXCEL™ Soft Vascular Graft
...um is intended for monitoring the accuracy and pre... It is for in vitro diagnostic use only. Provided ...rs up to ten days stability at 2 8°C once rec...e with the directions accompanying the assay proce...
AdvancedMD Medical Claims Billing
Medicine Products: